MUSTANG BIO INC (MBIO)

US62818Q2030 - Common Stock

0.3178  +0.02 (+8.46%)

After market: 0.3121 -0.01 (-1.79%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
50.73M76.16M66.72M56.81M45.89M
Research and Development
39.14M61.25M53.51M45.60M36.32M
Selling, General, and Administrative Expenses
9.69M12.21M11.02M9.51M9.57M
Operating Income
-50.73M-76.16M-66.72M-56.81M-45.89M
Interest Income/Expense
-3.26M-2.67M350.00K-3.21M-500.00K
Other Income/Expense
917.00K1.30MN/AN/AN/A
Non Recurring Items
1.47MN/AN/AN/AN/A
Income Before Taxes
-51.60M-77.53M-66.37M-60.02M-46.39M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-51.60M-77.53M-66.37M-60.02M-46.39M
EBITDA
-48.87M-73.44M-64.55M-55.13M-44.63M
 
Per Share Data
EPS Diluted Total Ops
-6.00-11.24-11.33-17.09-19.32
Non GAAP EPS
-6.32-11.25-3.84-1.15-1.30
 
Statistics

All data in USD

Charts